Michael J. Herrera, David J. Kuntz, and Martin E. Jacques. Determination of an Alternate Source of Methcathinone in a Patient Sample. SOFT Annual Meeting, Atlanta, GA. October 21, 2015.
David Kuntz. Synthetic Cannabinoid Use in the Workplace. Drug Testing 2011-2015: Use Patterns and Prevalence. DATIA Focus. Spring 2016: pages 28-33.
David Kuntz. Synthetic Cannabinoids are Constantly Evolving. Drug Screen Compliance Newsletter. May 2015.
David J. Kuntz. Synthetic Cannabinoids in the Workplace: Analysis of Three Years of Data. DATIA Focus. Spring 2015: pages 58-62.
David J. Kuntz. Synthetic Cannabinoids Continues to be Abused. Drug Screening Compliance Blog. August 2014.
David J. Kuntz. Testing for Alcohol Abuse in the Non-Regulated Workplace—Old and New Tests. DATIA Focus. Summer 2014: pages 44-45.
David J. Kuntz. Detecting Synthetic Urine – Team Approach Required. DATIA Focus. Winter 2014: pages 36-41.
David J. Kuntz. Emerging Alcohol Biomarkers. Clinical & Forensic Toxicology News. September 2013.
David J. Kuntz. Synthetic Cannabinoids Prevalence in the Workplace: A Twelve-Month Evaluation by Clinical Reference Laboratory. DATIA Focus. Winter 2013: pages 18-22.
Advanced Analytical Techniques for the Confirmation of Drugs. Medical Review Officer Handbook. 10th Edition 2014. Published by AAMRO.
We are active members within the workplace drug testing community through training, discussions, and other programs in effort to advance our industry. Please contact us for additional information and resources.